Clinical Trial

Polyprev: Study to Compare Fecal Immunochemical Test With Endoscopic Surveillance After Advanced Adenoma Resection in Fecal Immunochemical Test Colorectal Cancer Screening Programs.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Colorectal cancer (CRC) screening programs have been implemented to reduce the burden of the disease. When an advanced colonic lesions is detected, it is recommended to perform endoscopic surveillance with different intervals between explorations. Although the reduction in CRC incidence, endoscopic surveillance is producing a considerable increase in the number of colonoscopies. However, participation in CRC screening programs based on the fecal immunochemical test (FIT) could be a non inferior alternative to endoscopic surveillance. Based on this hypothesis, the research group have designed a randomized clinical trial within the population CRC screening programs to compare FIT surveillance to endoscopic surveillance in patients with advanced lesions resected.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-07-08; most recent amendment 2024-02-26.
Status change: Not Yet Recruiting → Recruiting 2023-03-23
Trial Details
NCT Number NCT04967183
Lead Sponsor Fundacin Biomedica Galicia Sur
Conditions Colorectal Cancer
Enrollment 3,788 participants
Start Date 2022-06-01
Primary Completion 2025-06 (estimated)
Study Completion 2035-06 (estimated)
Updated on ClinicalTrials.gov 2024-02-28